Physician profile
Omid Fatemi
NPI 1326293143
$66,278.83
in general payments reported to CMS, 2019-2025
40 companies · $29K in 2025
The $29K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,268 · 2020: $1,093 · 2021: $2,725 · 2022: $7,538 · 2023: $13K · 2024: $9,750 · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Food and Beverage: $12K · Travel and Lodging: $8,750 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,310.00 |
| Food and Beverage | $12,095.23 |
| Travel and Lodging | $8,749.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $51,862.28 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $5,595.47 | 2019-2025 | General - Therapies, Watchman Flx, Avvigo Guidance System |
| Abbott Laboratories | $1,848.01 | 2020-2025 | Triclip, Mitraclip, Aveir |
| Abiomed | $1,132.34 | 2019-2025 | Impella |
| Medtronic, INC. | $1,121.94 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Baylis Medical Company INC | $765.86 | 2019 | |
| Novartis Pharmaceuticals Corporation | $711.64 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $583.94 | 2019-2025 | Lifevest |
| Biosense Webster, INC. | $402.28 | 2024 | Nuvision Ice Catheter, Carto 3 |
| Biotronik INC. | $357.30 | 2019-2025 | Orsiro Mission |
| Amgen INC. | $245.76 | 2019-2022 | |
| Medtronic Vascular, INC. | $196.75 | 2019-2020 | |
| Ge Healthcare | $168.86 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $134.05 | 2019-2025 | Camzyos, Eliquis |
| Cardiva Medical, INC. | $125.48 | 2020-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
Show all 39 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omid Fatemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.